Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Marie Skłodowska-Curie Action · Running

METMAP Extracellular Vesicles as mediators of Pre-Metastatic Niche Formation in Melanoma

Coordinator
Vib Vzw, Belgium
Runs
1 June 2024 to 31 May 2026
Status
Running
EU funding
€176k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101150893

What the project is doing

In the project's own words, from its summary on CORDIS.

Every 2 minutes someone in the world is diagnosed with melanoma, so by the time you read this application dozens of new melanoma cases will be detected. Beyond its growing incidence, cutaneous melanoma is the most aggressive type of skin cancer and notorious for its high metastatic propensity, which constitutes the primary cause of death for these patients. Cellular heterogeneity and plasticity are key features of melanoma, supporting disease progression.

The host laboratory has recently charted a functional map of the melanoma ecosystem and identified a cell population that fuels tumor growth (pre-EMT) and another that functions as metastasis-initiating cells (MICs). Increasing evidence indicates that metastatic dissemination of MICs relies on the formation of favourable microenvironments, or pre-metastatic niches (PMN), at secondary sites, and that extracellular vesicles (EVs) shed by the primary tumour are key mediators of PMN formation.

I hypothesize that EVs produced by phenotypically distinct melanoma cells are likely to contain different biological information, and thus may exert different (possibly diverging) roles in PMNs formation. In METMAP, I will (i) determine the melanoma cell state(s) contributing to the formation of PMNs via EVs; (ii) dissect the molecular mechanisms underlying PMN formation; and (iii) unravel how these mechanisms facilitate metastatic spreading.

I will leverage my background in EVs biology and establish melanoma cell state-reporters to track EV-mediated communication between melanoma subpopulations and PMNs. Proximity labelling will be used to dissect the bioactive contents of EVs transferred to PMNs and perturbation experiments will be conducted to decipher this complex interplay. Through METMAP, I will deliver a functional understanding of how distinct melanoma states contribute to the development of PMN and, ultimately, identify new targets for disruptive therapies that hinder melanoma metastasis.

Topics

Who is involved

OrganisationCityCountryRole
Vib VzwZwijnaarde - GentBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI